Siplizumab Clinical Trials
2 recruitingDrug
Early Phase 11Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of SIPLIZUMAB in AILD and LT Patients
Autoimmune HepatitisPrimary Sclerosing CholangitisLiver Transplant Disorder+1 more
Elizabeth C. Verna8 enrolled1 locationNCT06455280
Recruiting
Early Phase 1
An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Hidradenitis Suppurativa
University of Alabama at Birmingham12 enrolled1 locationNCT06326476